Clinical Trial

Study on Risk Factors and Prognosis of MASLD

Name: Study on Risk Factors and Prognosis of MASLD — clinical trial record (NCT07433205)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed

View on ClinicalTrials.gov →

Summary

This longitudinal cohort study will enroll individuals with MASLD (and/or those at risk) and follow them over time to identify clinical and metabolic risk factors for disease progression and to evaluate predictors of long-term outcomes, including fibrosis progression and liver-related events, major cardiovascular events, and all-cause mortality.

Trial Details

NCT Number	NCT07433205
Lead Sponsor	First Affiliated Hospital of Chongqing Medical University
Conditions	Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Enrollment	922 participants
Start Date	2024-01-01
Primary Completion	2025-12-31 (estimated)
Study Completion	2025-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-02-25